Back to Search
MARY KORT, PHARMD
PHARMD
Pharmacist
NPI: 1790211688Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
56208(CA)
Research & Publications (19)
Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
PMID 18176998·J Med Chem·2008
7-preclinical
Voltage-gated sodium channel blockers for the treatment of chronic pain.
PMID 19442207·Curr Top Med Chem·2009
6-review
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
PMID 19135797·Pain·2009
7-preclinical
Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
PMID 19070548·J Pain·2009
7-preclinical
Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
PMID 18755179·Eur J Pharmacol·2008
4-observational
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
PMID 18501613·Bioorg Med Chem·2008
7-preclinical
Molecular determinants of species-specific activation or blockade of TRPA1 channels.
PMID 18463259·J Neurosci·2008
7-preclinical
A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats.
PMID 18089840·J Pharmacol Exp Ther·2008
4-observational
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
PMID 17973362·J Med Chem·2007
7-preclinical
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
PMID 17483457·Proc Natl Acad Sci U S A·2007
7-preclinical
P2X7-related modulation of pathological nociception in rats.
PMID 17478048·Neuroscience·2007
7-preclinical
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
PMID 17154517·J Med Chem·2006
7-preclinical
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
PMID 16759108·J Med Chem·2006
7-preclinical
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.
PMID 15163197·J Med Chem·2004
7-preclinical
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.
PMID 15163196·J Med Chem·2004
7-preclinical
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
PMID 14698167·Bioorg Med Chem Lett·2004
7-preclinical
The pursuit of differentiated ligands for the glucocorticoid receptor.
PMID 14683518·Curr Top Med Chem·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15684 CANON LN
CHINO HILLS, CA 91709 - Phone
- (714) 936-6171
Quick Facts
- NPI
- 1790211688
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile